Jump to content

Serostim

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Where are the refs? (talk | contribs) at 02:53, 24 June 2018 (Added source to court order - this was not a settlement). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for HIV-associated wasting.[1]

In December 2007, the U.S. District Court of Massachusetts - in a class-action lawsuit that involved Merck Serono and Serostim - fined Serono a total of $704 million in criminal and civil liabilities for enacting "illegal schemes to promote, market and sell its drug."[2]

References

  1. ^ http://www.serostim.com/
  2. ^ "SERONO TO PAY $704 MILLION FOR THE ILLEGAL MARKETING OF AIDS DRUG". Department of Justice. 17 October 2005. Retrieved 23 June 2018.

http://www.serostimsettlement.com